Cancer Research · 2016 · 15 citations · 34 references
MedicineDermatologyPharmacologyCutaneous OncologySpectroscopic AnalysisSpectroscopyBiomarker AnalysisCancer BiomarkersMolecular SpectroscopyOptical SpectroscopyPharmacodynamics Of Anticancer AgentsRaman SpectroscopyCutaneous Adverse EventsDrug Concentration PredictionEgfr InhibitionPartial Least Squares Discriminant AnalysisPharmacodynamic Biomarker DiscoveryPredictors Of Severe ToxicityRaman SpectraSpectroscopic Biomarker Detection
Raman spectroscopy is a noninvasive and label-free optical technique that provides detailed information about the molecular composition of a sample. In this study, we evaluated the potential of Raman spectroscopy to predict skin toxicity due to tyrosine kinase inhibitors treatment. We acquired Raman spectra of skin of patients undergoing treatment with MEK, EGFR, or BRAF inhibitors, which are known to induce severe skin toxicity; for this pilot study, three patients were included for each inhibitor. Our algorithm, based on partial least squares-discriminant analysis (PLS-DA) and cross-validation by bootstrapping, discriminated to variable degrees spectra from patient suffering and not suffering cutaneous adverse events. For MEK and EGFR inhibitors, discriminative power was more than 90% in the viable epidermis skin layer; whereas for BRAF inhibitors, discriminative power was 71%. There was a 81.5% correlation between blood drug concentration and Raman signature of skin in the case of EGFR inhibitors and viable epidermis skin layer. Our results demonstrate the power of Raman spectroscopy to detect apparition of skin toxicity in patients treated with tyrosine kinase inhibitors at levels not detectable via dermatological inspection and histological evaluation. Cancer Res; 77(2); 557-65. ©2016 AACR.
34
Index for rating diagnostic tests
W. J. Youden · Cancer · 1950 · 11.5K citations · Full text
Education, Educational Assessment, Educational Measurement +11
A Study of Cross-Validation and Bootstrap for Accuracy Estimation and Model Selection
Ron Kohavi · 1995 · 10.7K citations · Full text
Mutations of the BRAF gene in human cancer
Helen Davies, Graham R. Bignell, Charles Cox et al. · Nature · 2002 · 10.7K citations